<code id='A96FCDEF69'></code><style id='A96FCDEF69'></style>
    • <acronym id='A96FCDEF69'></acronym>
      <center id='A96FCDEF69'><center id='A96FCDEF69'><tfoot id='A96FCDEF69'></tfoot></center><abbr id='A96FCDEF69'><dir id='A96FCDEF69'><tfoot id='A96FCDEF69'></tfoot><noframes id='A96FCDEF69'>

    • <optgroup id='A96FCDEF69'><strike id='A96FCDEF69'><sup id='A96FCDEF69'></sup></strike><code id='A96FCDEF69'></code></optgroup>
        1. <b id='A96FCDEF69'><label id='A96FCDEF69'><select id='A96FCDEF69'><dt id='A96FCDEF69'><span id='A96FCDEF69'></span></dt></select></label></b><u id='A96FCDEF69'></u>
          <i id='A96FCDEF69'><strike id='A96FCDEF69'><tt id='A96FCDEF69'><pre id='A96FCDEF69'></pre></tt></strike></i>

          focus

          focus

          author:knowledge    Page View:55
          Martin Shkreli Securities Fraud Trial
          Kevin Hagen/Getty Images

          Is this the end of the line for the “pharma bro” with the perpetual smirk?

          Martin Skhreli was found guilty on Friday of three counts of fraud after a five-week trial in federal court in Brooklyn, N.Y. He faces a prison sentence that could stretch years.

          advertisement

          “This was a witch hunt of epic proportions,” Shkreli said outside court after the verdict, the Washington Post reported. “They may have found some broomsticks.”

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          knowledge

          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more
          EU regulator recommends expanding Mounjaro approval to obesity
          EU regulator recommends expanding Mounjaro approval to obesity

          PauloAmorim/VWPicsviaAPImagesLONDON—TwodaysaftersimilardecisionsintheU.S.andU.K.,regulatorsinEuropeo

          read more
          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more

          What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s rise

          MollyFerguson/STATHello!SometakesandthoughtsonGilead’sTrodelvytroubles,ElevationOncology’ssurprising